Answers are grounded in this paper and cite their sources.
Azetidin-2-ones (β-lactams) and its derivatives are an important group of heterocyclic compounds that exhibit a wide range of pharmacological properties such as antibacterial, anticancer, anti-diabetic, anti-inflammatory and anticonvulsant. Efforts have been made over the years to develop novel congeners with superior biological activities and minimal potential for undesirable side effects. The present review aimed to highlight some recent discoveries (2013-2019) on the development of novel azetidin-2-one-based compounds as potential anticancer agents.
No takes yet. Share an insight, caveat, or question.
Pinto et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: